Apatinib for molecular targeted therapy in tumor

被引:195
作者
Zhang, Haijun [1 ]
机构
[1] Southeast Univ, Dept Oncol, Zhongda Hosp, Sch Med, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
apatinib; angiogenesis; vascular endothelial growth factor receptor-2; molecular targeted therapy; tumor; GROWTH-FACTOR RECEPTOR-2; MULTICENTER PHASE-II; MULTIDRUG-RESISTANCE; BREAST-CANCER; GASTRIC-CANCER; IN-VITRO; INHIBITOR; YN968D1; PHARMACOKINETICS; EFFICACY;
D O I
10.2147/DDDT.S97235
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As tumor angiogenesis is one of the hallmarks of cancer, the inhibition of vascular endothelial growth factor signaling has become an attractive anticancer approach. Apatinib, a small-molecule inhibitor of vascular endothelial growth factor receptor-2, has demonstrated encouraging anticancer activity across a broad range of malignancies, including gastric cancer, non-small-cell lung cancer, breast cancer, and hepatocellular carcinoma. In this up-to-date review, focus is not only on the structure, mechanisms, and pharmacokinetics of apatinib, but also on summarizing clinical trials and making recommendations of apatinib for patients with advanced solid tumors.
引用
收藏
页码:6075 / 6081
页数:7
相关论文
共 36 条
[1]   Global trends in breast cancer incidence and mortality 1973-1997 [J].
Althuis, MD ;
Dozier, JM ;
Anderson, WF ;
Devesa, SS ;
Brinton, LA .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2005, 34 (02) :405-412
[2]   Efficacy of biological agents in metastatic triple-negative breast cancer [J].
Bramati, Annalisa ;
Girelli, Serena ;
Torri, Valter ;
Farina, Gabriella ;
Galfrascoli, Elena ;
Piva, Sheila ;
Moretti, Anna ;
Dazzani, Maria Chiara ;
Sburlati, Paola ;
La Verde, Nicla Maria .
CANCER TREATMENT REVIEWS, 2014, 40 (05) :605-613
[3]   Comparison of effects of anti-angiogenic agents in the zebrafish efficacy-toxicity model for translational anti-angiogenic drug discovery [J].
Chimote, Geetanjali ;
Sreenivasan, Jayasree ;
Pawar, Nilambari ;
Subramanian, Jyothi ;
Sivaramakrishnan, Hariharan ;
Sharma, Somesh .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 :1107-1123
[4]   Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors [J].
Clark, JW ;
Eder, JP ;
Ryan, D ;
Lathia, C ;
Lenz, HJ .
CLINICAL CANCER RESEARCH, 2005, 11 (15) :5472-5480
[5]   Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis [J].
Clark, Otavio ;
Ayer Botrel, Tobias Engel ;
Paladini, Luciano ;
Andrade Ferreira, Mariana Bhering .
CORE EVIDENCE, 2014, 9 :1-11
[6]   Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma [J].
Cowey, C. Lance .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 :519-527
[7]   Metabolism and Pharmacokinetics of Novel Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor Apatinib in Humans [J].
Ding, Juefang ;
Chen, Xiaoyan ;
Gao, Zhiwei ;
Dai, Xiaojian ;
Li, Liang ;
Xie, Cen ;
Jiang, Haoyuan ;
Zhang, Lijia ;
Zhong, Dafang .
DRUG METABOLISM AND DISPOSITION, 2013, 41 (06) :1195-1210
[8]   Simultaneous determination of apatinib and its four major metabolites in human plasma using liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study [J].
Ding, Juefang ;
Chen, Xiaoyan ;
Dai, Xiaojian ;
Zhong, Dafang .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 895 :108-115
[9]   Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy [J].
Fan, Minhao ;
Zhang, Jian ;
Wang, Zhonghua ;
Wang, Biyun ;
Zhang, Qunlin ;
Zheng, Chunlei ;
Li, Ting ;
Ni, Chen ;
Wu, Zhenhua ;
Shao, Zhimin ;
Hu, Xichun .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (01) :141-151
[10]   Clinical advances in the development of novel VEGFR2 inhibitors [J].
Fontanella, Caterina ;
Ongaro, Elena ;
Bolzonello, Silvia ;
Guardascione, Michela ;
Fasola, Gianpiero ;
Aprile, Giuseppe .
ANNALS OF TRANSLATIONAL MEDICINE, 2014, 2 (12)